Ofloxacin Current Affairs - 2019
Category Wise PDF Compilations available at This Link
After the alerts from the Pharmacovigilance Programme of India (PvPI) the Central Drugs Standard Control Organisation (CDSCO) has asked manufacturers of 7 common antibiotics to ensure that information related to symptoms/side effects is made available to the general public.
- CDSCO has asked drug manufacturers, to mention in leaflets inserted into drug packets or on promotional literature, information about the adverse reactions of these medicines.
- Manufacturers of antibiotics Cefotaxime, Ofloxacin and Cefixime; Tranexamic Acid ( used to control bleeding) antipsychotic drug Quetiapine; anti-rheumatoid drug Sulfasalazine and the anti-epileptic medicine Sodium Valproate are instructed to warn patients of the “new” side effects.
Pharmacovigilance Programme of India
Pharmacovigilance Program of India (PvPI) was launched in 2010 with a broad objective to safeguard the health of 1.27 billion people of India. Adverse drug Reactions (ADRs) are reported from all over the country to the National Coordination centre of PvPI, which also work in collaboration with the global ADR monitoring centre (WHO-UMC), Sweden to contribute in the global ADRs database.
The Indian Pharmacopoeia Commission (IPC), Ghaziabad, (U.P.) hosts the coordination centre for PvPI. The mission of PvPI is to safeguard the health of the Indian population by ensuring that the benefit of the use of medicine outweighs the risks associated with its use.
Tags: Adverse drug Reactions • CDSCO • Cefixime • Cefotaxime • Central Drugs Standard Control Organisation • Ghaziabad • Indian Pharmacopoeia Commission • IPC • Ofloxacin • Pharmacovigilance Programme of India • PvPI • Quetiapine • Sodium Valproate • Sulfasalazine • Tranexamic Acid
The Revenue Department in the Finance Ministry has imposed anti-dumping duty on import of ‘Ofloxacin’, a pharma product used in treatment of certain infections from China. It was imposed for three years following recommendations of Directorate General of Anti-Dumping and Allied Duties (DGAD) to protect domestic producers from below-cost shipments. In its probe DGAD had found that Ofloxacin exported to India from China was below its normal value, resulting in dumping. It had caused material injury to the domestic industry.
Ofloxacin is in class of antibiotics called fluoroquinolones. It is used to treat certain infections including bronchitis, pneumonia and infections of skin, bladder, urinary tract, reproductive organs, and prostate (a male reproductive gland). It works by killing bacteria that cause infections.
It is an import duty imposed by government on imported products which have prices less than their normal values or domestic price. It act as a protectionist and counter import measure used by a country under multilateral World Trade Organisation (WTO) regime to protect its domestic producers and market from below-cost/cheap imports. The duty is aimed at ensuring fair trading practises and creating level-playing field for domestic producers with regard to foreign producers and exporters. It varies from product to product and from country to country. In India, anti-dumping duty to be levied is recommended by Ministry of Commerce (i.e. by DGAD), while Finance Ministry imposes it.